Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications

K Venkatesh, SK Ghosh, M Mullick… - Cell and tissue …, 2019 - Springer
Axonal regeneration and formation of tripartite (axo-glial) junctions at damaged sites is a
prerequisite for early repair of injured spinal cord. Transplantation of stem cells at such sites …

iPS cells: a game changer for future medicine

H Inoue, N Nagata, H Kurokawa, S Yamanaka - The EMBO journal, 2014 - embopress.org
The induced pluripotent stem cell (i PSC) technology is instrumental in advancing the fields
of disease modeling and cell transplantation. We herein discuss the various issues …

[HTML][HTML] Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01

J Piao, S Zabierowski, BN Dubose, EJ Hill, M Navare… - Cell stem cell, 2021 - cell.com
Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia
nigra leading to disabling deficits. Dopamine neuron grafts may provide a significant …

First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol

K Sugai, M Sumida, T Shofuda, R Yamaguchi… - Regenerative …, 2021 - Elsevier
Introduction Our group has conducted extensive basic and preclinical studies of the use of
human induced pluripotent cell (iPSC)-derived neural stem/progenitor cell (hiPSC-NS/PC) …

Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease

PJ Hallett, M Deleidi, A Astradsson, GA Smith… - Cell stem cell, 2015 - cell.com
Autologous transplantation of patient-specific induced pluripotent stem cell (iPSC)-derived
neurons is a potential clinical approach for treatment of neurological disease. Preclinical …

MHC matching improves engraftment of iPSC-derived neurons in non-human primates

A Morizane, T Kikuchi, T Hayashi, H Mizuma… - Nature …, 2017 - nature.com
The banking of human leukocyte antigen (HLA)-homozygous-induced pluripotent stem cells
(iPSCs) is considered a future clinical strategy for HLA-matched cell transplantation to …

Development, wiring and function of dopamine neuron subtypes

O Garritsen, EY van Battum, LM Grossouw… - Nature Reviews …, 2023 - nature.com
The midbrain dopamine (mDA) system is composed of molecularly and functionally distinct
neuron subtypes that mediate specific behaviours and are linked to various brain diseases …

Human tyrosine hydroxylase in Parkinson's disease and in related disorders

T Nagatsu, A Nakashima, H Ichinose… - Journal of neural …, 2019 - Springer
Parkinson's disease (PD) is an aging-related movement disorder mainly caused by a
deficiency of neurotransmitter dopamine (DA) in the striatum of the brain and is considered …

Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium

JR Soucy, EA Aguzzi, J Cho, MJ Gilhooley… - Molecular …, 2023 - Springer
Retinal ganglion cell (RGC) death in glaucoma and other optic neuropathies results in
irreversible vision loss due to the mammalian central nervous system's limited regenerative …

The immunogenicity and immune tolerance of pluripotent stem cell derivatives

X Liu, W Li, X Fu, Y Xu - Frontiers in immunology, 2017 - frontiersin.org
Human embryonic stem cells (hESCs) can undergo unlimited self-renewal and differentiate
into all cell types in human body, and therefore hold great potential for cell therapy of …